期刊文献+

Cyr61上调人角质形成细胞系表达趋化因子与银屑病发生机制初探 被引量:2

Chemokines mRNA expression in HaCat induced by Cyr61 and potential relationship in pathogenesis of psoriasis
原文传递
导出
摘要 银屑病是一种常见的慢性炎症性皮肤疾病,多种炎症细胞与炎症因子参与其发病。我们已有研究发现促炎因子Cyr61/CCN1通过活化角质细胞而加剧皮损,但是否还有其他促炎机制尚不清楚。本研究通过Cyr61介导角质细胞产生趋化因子的体外实验,探讨Cyr61参与银屑病发生新途径。采用Real-time PCR方法检测人角质形成细胞系(HaCat细胞)在外源性Cyr61作用下趋化因子的表达格局。实验结果显示Cyr61能够在体外促进人角质形成细胞系表达多种趋化因子(如CCL2,CCL17,CCL22,CXCL1,CXCL10,CXCL11(P<0.05)),提示Cyr61可能通过促进角质形成细胞系表达多种趋化因子从而参与DC,Th17,Th1等细胞的趋化。提示Cyr61可能通过促进角质形成细胞系表达趋化因子介导炎性细胞局部浸润增多,加剧银屑病发病。 Psoriasis is a common chronic inflammatory skin disease, and many kinds of inflammatory cells and inflammatory factors are involved in the pathogenesis of psoriasis. Our previous studies indicate that Cyr61, a proinflammatory factor, is in- volved in the pathogenesis and development of psoriasis by promoting keratinocyte activation and proliferation resulting in ag- gravation of the skin lesions. However, whether there are other proinflammatory activity promoted by Cyr61 still remains un- clear, Therefore, in this study, we analyzed the expression profile of chemokines upon Cyr61 stimulation in vitro to explore a new pathogenesis of psoriasis. Real-time PCR was used to detect the chemokine expression pattern of HaCat cell line upon Cyr61 stimulation. Cyr61 could up-regulate the expression of multiple chemokines in HaCaT cells, such as CCL2, CCL17, CCL22, CXCL1, CXCL10,CXCL11 (P^0.05) to promote potentially DC, Th17, Thl and other cells infiltration in local skin lesions. The results indicate that Cyr61 might enhance the inflammatory cells infiltration to participate in the pathogenesis of psoriasis by inducing the expression of chemokines.
出处 《现代免疫学》 CAS CSCD 北大核心 2016年第5期377-381,共5页 Current Immunology
基金 上海市科技委员会重点项目(13JC1402300)
关键词 银屑病 CYR61 趋化因子 HACAT细胞 psoriasis Cyr61 chemokine HaCat cell
  • 相关文献

参考文献17

  • 1李玲玲,张玉杰.趋化因子在银屑病发病机制中的研究进展[J].国际皮肤性病学杂志,2013,39(3):185-188. 被引量:1
  • 2苏艳宾,李倩如,高峰,张清勇,杜英.趋化因子及其受体在重症肌无力患者胸腺组织的异常表达[J].现代免疫学,2011,31(3):248-252. 被引量:4
  • 3Nedoszytko B,Sokolowska-Wojdylo M,Ruckemann-Dziurdzińska K,et al.Chemokines and cytokines network in the pathogenesis of the inflammatory skin diseases:atopic dermatitis,psoriasis and skin mastocytosis[J].Postep Derm Alergol,2014,31:84-91.
  • 4Lonsdorf AS,Hwang ST,Enk AH.Chemokine receptors in T-cell.mediated diseases of the skin[J].Invest Dermatol,2009,129:2552-2566.
  • 5Mabuchi T,Takekoshi T,Hwang ST.Epidermal CCR6+γδT cells are major producers of IL-22and IL-17in a murine model of psoriasiform dermatitis[J].Immunology,2011,187:5026-5031.
  • 6Di Cesare A.Di Meglio P Nestle FO.The IL-23/Th17axis in the immunopathogenesis of psoriasis[J].Invest Dermatol,2009,129:1339-1350.
  • 7Sun Y,Zhang J,Zhou Z,et al.CCN1,a Pro-Inflammatory Factor,Aggravates Psoriasis Skin Lesions by Promoting Keratinocyte Activation[J].J Invest Dermatol,2015,135:2666-2675.
  • 8Kim J,Krueger JG.The immunopathogenesis of psoriasis[J].Dermatol Clin,2015,33:13-23.
  • 9Quan T,Johnston A,Gudjonsson JE,et al.CYR61/CCN1:A Novel Mediator of Epidermal Hyperplasia and Inflammation in Psoriasis&quest[J].J Invest Dermatol,2015,135:2562-2564.
  • 10贺超,董萍云,褚京津,简瑜,任占芬,孟凡茹.寻常型银屑病患者血清中IL-21、IL-31的表达水平[J].现代免疫学,2013,33(3):225-228. 被引量:1

二级参考文献61

  • 1唐秀娟,臧敬五.趋化因子系统与中枢神经系统炎症性疾病[J].现代免疫学,2007,27(2):173-176. 被引量:6
  • 2Smit JJ, Lukacs NW. A closer look at chemikines and their role in asthmatic responses[ J]. Eur J Pharmacol, 2006, 533:277 - 288.
  • 3Morimoto Y, Bian Y, Gao P, et al. Induction of surface CCR4 and its functionality in mouse Th2 cells is regulated differently during Th2 developmentI J]. J Leuko Biol, 2005,78 (3) :753 - 761.
  • 4Yoshie O. Expression of CCR4 in adult T-cell leukemia [ J ]. Leukemia Lymphoma, 2005,46 (2) : 185 - 190.
  • 5Chvatchko Y, Hoogewerf A J, Meyer A, et al. A key role for CC chemokine receptor 4 in lipopolysaccharide-induced endotoxic shock[J]. J Exp Med, 2000, 191 (10) :1755 - 1764.
  • 6Huser A, et al. CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model [J]. Eur J lmmunol, 2005, 35( 1 ) :128 - 138.
  • 7Purandare AV, Gao A, Wan HH, et al. Identification of chemokine receptor CCR4 antagonist [J]. Bioorg Med Chem Lett, 2005, 15(10) :2669 -2672.
  • 8Purandare AV, Wan HH, Somerville JE, et al. Core exploration in optimization of chemokine receptor CCR4 antagonists [J]. Bioorg Med Chem Lett, 2007, 17(3 ) :679 -682.
  • 9Yokoyama K, Ishikawa N, Igarashi S, et al. Discovery of potent CCR4 antagonists: synthesis and structure-activity relationship study of 2,4-diaminoquinazolines[J]. Bioorg Med Chem, 2008, 16(14) :7021 - 7032.
  • 10Nakagami Y, Kawashima K, Yonekubo K, et al. Novel CC chemokine receptor 4 antagonists RS-1154 inhibits ovalbumin-induced ear swelling in mice [ J ]. Eur J Pharmacol, 2009, 624 (1 -3) :38 -44.

共引文献4

同被引文献1

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部